Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
The summary for the Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional): Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.
Federal Grant Title: | Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education, Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-25-079 |
Type of Funding: | Grant |
CFDA Numbers: | 93.394, 93.395 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | January 7th, 2027 |
Original Application Deadline: | January 7th, 2027 |
Posted Date: | November 6th, 2024 |
Creation Date: | November 6th, 2024 |
Archive Date: | February 12th, 2027 |
Total Program Funding: | $500,000 |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | November 6th, 2024 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PAR-25-079.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
- • Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Tria...
- • Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Tria...
- • Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • Image-Guided Cancer Interventions (STTR [R41/R42])
- • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
- • In Vivo Cancer Imaging Exploratory/Developmental Grants
- More Grants from the National Institutes of Health
- • Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- • Alcohol Health Services Research (R01 Clinical Trial Optional)
- • Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- • Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Re...
- • Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the...